Home
Email:
Password:
Forget your password?
Eric Zwisler, China Regional Director of Zuellig Pharma
More podcasts
Monday, December 1, 2008
Lilly continues with USD 100 million China venture investment plans
FDA finds melamine in US infant formula, says trace levels pose no threat
Free access
Friday, November 28, 2008
Knock at the door? Could be Harbin Pharmaceutical- now allowed direct sales
Golden Meditech to issue 60 million shares to Atlantis Investment
Shanghai researchers find gene modification potential treatment for HCC
OTC's bright future? 33% of Chinese self-medicate (but many choose no meds)
Free access
Liang of prevention = jin of cure? China to shift healthcare focus, says MOH
Free access
Thursday, November 27, 2008
Another step for stem cell medicine: potential cure for diabetic foot infection
Chinese scientists use gene modification to reduce blood glucose levels
Amity Foundation establishes autism community center in Nanjing
Smiths Medical pumps up its China med device biz with Zhejiang acquisition
Wednesday, November 26, 2008
Shanghai introduces preferential policies to entice docs to community hospitals
GE Healthcare targets China rural market
Diabetes Educator Training program launches in Beijing
A new precedent? Physicians practice in multiple institutions in Yunnan
Tuesday, November 25, 2008
WHO: heart disease, stroke, diabetes to cost China USD 558 billion
Free access
Hubei pharmacies create alliance, raise concerns over monopoly
US HHS Secretary: FDA to use 3rd party inspectors to monitor China food exports
Peking University and JCI establish service quality/patient safety institute
Free access
Taiwanese hospitals encourage cross-straits medical tourism
Monday, November 24, 2008
Hospital directors weigh in on reform
Capital Today for growth tomorrow: Yifeng Super Drugstore receives RMB 200M
Free access
China first nation to classify internet addiction as mental disorder
BMP Sunstone follows gut feelings: acquires constipation drug from Darentang
Free access
Grassroots healthcare to receive chunk of stimulus package
About us
|
Contact us
|
FAQ
|
Feedback
© GB Group limited. All right reserved.
pharmaceutical,china pharmaceutical,pharm,pharmhound,generalbiologic,China drug,Drug discovery,Pharmaceutical market,China Antibody,China preclinical,China clinical trial,China CRO,China API,Matthew Chervenak,China research and development,China hepatitis,China cancer,China diabetes,China oncology,China cardiovascular,China CNS,China disease